|
Volumn 36, Issue 4, 2004, Pages 1055-1057
|
African-American ethnicity is no longer a risk factor for early adverse outcomes in simultaneous kidney-pancreas transplantation with contemporary immunosuppression
|
Author keywords
[No Author keywords available]
|
Indexed keywords
C PEPTIDE;
DACLIZUMAB;
HEMOGLOBIN A1C;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
STEROID;
TACROLIMUS;
ADULT;
AFRICAN AMERICAN;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEMOGRAPHY;
ETHNOLOGY;
FEMALE;
GRAFT REJECTION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY FUNCTION;
KIDNEY GRAFT;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
PANCREAS TRANSPLANTATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
SIDE EFFECT;
SIMULTANEOUS KIDNEY PANCREAS TRANSPLANTATION;
SURVIVAL RATE;
ADULT;
AFRICAN AMERICANS;
ETHNIC GROUPS;
FEMALE;
HUMANS;
IMMUNOSUPPRESSION;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MALE;
PANCREAS TRANSPLANTATION;
RISK FACTORS;
TREATMENT FAILURE;
TREATMENT OUTCOME;
|
EID: 2942670735
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2004.04.045 Document Type: Conference Paper |
Times cited : (12)
|
References (10)
|